Company news
Absci Corporation news in 2023
Absci Corporation's news releases, calls and decks from 2023, newest first.
Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
December 19, 2023
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
December 3, 2023
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
November 13, 2023
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
November 13, 2023
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
September 20, 2023
Absci to Host R&D Day on October 4, 2023
September 5, 2023
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
August 13, 2023
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
August 13, 2023
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
August 9, 2023
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
July 31, 2023
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 25, 2023
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
June 14, 2023
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
June 5, 2023
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
May 14, 2023
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
May 10, 2023
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 5, 2023
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
April 3, 2023
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
March 29, 2023
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
March 22, 2023
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 6, 2023
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
February 27, 2023
Absci to Participate in the 43rd Annual Cowen Health Care Conference
February 20, 2023
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
February 8, 2023
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
February 7, 2023
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
January 9, 2023
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 7, 2023